Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The frameless copper IUD (GyneFix) and the TCu380A IUD: results of an 8-year multicenter randomized comparative trial.
Meirik O, Rowe PJ, Peregoudov A, Piaggio G, Petzold M; IUD Research Group at the UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction. Meirik O, et al. Contraception. 2009 Aug;80(2):133-41. doi: 10.1016/j.contraception.2009.02.006. Epub 2009 Mar 31. Contraception. 2009. PMID: 19631788 Clinical Trial.
Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A.
Rowe P, Farley T, Peregoudov A, Piaggio G, Boccard S, Landoulsi S, Meirik O; IUD Research Group of the UNDP/UNFPA/WHO/World Bank Special Programme of Research; Development and Research Training in Human Reproduction. Rowe P, et al. Among authors: meirik o. Contraception. 2016 Jun;93(6):498-506. doi: 10.1016/j.contraception.2016.02.024. Epub 2016 Feb 23. Contraception. 2016. PMID: 26916172 Free PMC article. Clinical Trial.
Corrigendum to "Rowe P et al. safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A" [Contraception 2016;93:498-506].
Rowe P, Farley T, Peregoudov A, Piaggio G, Boccard S, Landoulsi S, Meirik O; IUD Research Group of the UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction. Rowe P, et al. Among authors: meirik o. Contraception. 2016 Sep;94(3):288. doi: 10.1016/j.contraception.2016.06.001. Epub 2016 Jun 14. Contraception. 2016. PMID: 27312266 Free PMC article. No abstract available.
A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
Bahamondes L, Brache V, Meirik O, Ali M, Habib N, Landoulsi S; WHO Study Group on Contraceptive Implants for Women. Bahamondes L, et al. Among authors: meirik o. Hum Reprod. 2015 Nov;30(11):2527-38. doi: 10.1093/humrep/dev221. Epub 2015 Sep 25. Hum Reprod. 2015. PMID: 26409014 Clinical Trial.
A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.
Meirik O, Brache V, Orawan K, Habib NA, Schmidt J, Ortayli N, Culwell K, Jackson E, Ali M; WHO Study Group on Contraceptive Implants for Women. Meirik O, et al. Contraception. 2013 Jan;87(1):113-20. doi: 10.1016/j.contraception.2012.08.044. Epub 2012 Oct 10. Contraception. 2013. PMID: 23063337 Clinical Trial.
Implantable contraceptives for women.
Meirik O. Meirik O. Contraception. 2002 Jan;65(1):1-2. doi: 10.1016/s0010-7824(01)00282-7. Contraception. 2002. PMID: 11861048 No abstract available.
104 results